Columbia Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Columbia Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$884K	Sell	5,875 -1,390	-19%	-$188K	0.18%	90
2021 Q3	$867K	Buy	7,265 +1,480	+26%	+$163K	0.19%	90
2021 Q2	$563K	Sell	5,785 -1,030	-15%	-$91.8K	0.12%	115
2021 Q1	$601K	Buy	6,815 +635	+10%	+$59K	0.11%	115
2020 Q4	$591K	Sell	6,180 -1,205	-16%	-$124K	0.12%	116
2020 Q3	$838K	Buy	7,385 +640	+9%	+$67.2K	0.19%	86
2020 Q2	$667K	Buy	+6,745	New	+$538K	0.16%	96

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Columbia Asset Management's TNDM Position: Q4 2021 in Review

Columbia Asset Management reduced its Tandem Diabetes Care (TNDM) stake by 19% in Q4 2021, selling an estimated $188K and leaving 5,875 shares worth $884K. The position accounts for 0.18% of the portfolio, ranked #90.

Columbia Asset Management first reported a position in TNDM in Q2 2020 and has held it in 7 quarters since. 388 funds tracked by Wall St. Rank hold TNDM as of Q4 2021.

Columbia Asset Management held 5,875 shares of Tandem Diabetes Care worth $884K as of Q4 2021.
Columbia Asset Management sold 1,390 Tandem Diabetes Care shares in Q4 2021, an estimated $188K.
Tandem Diabetes Care made up 0.18% of Columbia Asset Management's portfolio in Q4 2021, its #90 holding.
Columbia Asset Management first reported a position in Tandem Diabetes Care in Q2 2020 and has held it in 7 quarters since.
388 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2021.

Based on Columbia Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.